MORGAN STANLEY PLC/CALL/ELI LILLY & CO/380/0.01/20.12.24 | Market Closed - Börse Stuttgart 12:28:44 29/06/2024 am IST | ||
| 5.07 EUR | +0.80% |
|
| Current month | +22.17% | ||
| 1 month | +23.96% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 28/24/28 | 5.07 | +0.80% |
| 27/24/27 | 5.03 | -0.20% |
| 26/24/26 | 5.04 | +0.40% |
| 25/24/25 | 5.02 | +1.62% |
| 24/24/24 | 4.94 | +1.65% |
Delayed Quote Börse Stuttgart
Last update June 29, 2024 at 12:28 am IST
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | Morgan Stanley |
| WKN | MB4BJK |
| ISIN | DE000MB4BJK2 |
| Date issued | 13/03/2023 |
| Strike | 380 $ |
| Maturity | 20/12/2024 (174 Days) |
| Parity | 100 : 1 |
| Emission price | 0.42 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 5.12 € |
|---|---|
| Lowest since issue | 0.35 € |
| Delta | 0.97x |
| Omega | 1.619 |
| Premium | 1.65x |
| Gearing | 1.68x |
| Moneyness | 2.383 |
| Difference Strike | -525.4 $ |
| Difference Strike % | -138.26% |
| Spread | 0.01 € |
| Spread % | 0.20% |
| Theoretical value | 5.045 |
| Implied Volatility | 81.49 % |
| Total Loss Probability | 9.720 % |
| Intrinsic value | 4.905 |
| Present value | 0.1397 |
| Break even | 920.34 € |
| Theta | -0.01x |
| Vega | 0x |
| Rho | 0.01x |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
905.4
USD
Average target price
868.9
USD
Spread / Average Target
-4.03%
- Stock Market
- Warrants
- Warrant
